GeneDx Holdings WGS Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by GeneDx Holdings in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: GeneDx Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about GeneDx Holdings's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is GeneDx Holdings's financing cash flow?
- GeneDx Holdings (WGS) reported financing cash flow of $38.59M in Q1 2026.
- How has GeneDx Holdings's financing cash flow changed year-over-year?
- GeneDx Holdings's financing cash flow increased by 181.3% year-over-year, from $13.72M to $38.59M.
- What is the long-term trend for GeneDx Holdings's financing cash flow?
- Over 4 years (2021 to 2025), GeneDx Holdings's financing cash flow has grown at a -44.2% compound annual growth rate (CAGR), from $494.76M to $48.03M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.